Simplex Trading
OLMA icon

Simplex Trading’s Olema Pharmaceuticals OLMA Stock Holding History

Simplex Trading’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Sell
1,000
-30,200
-97% -$405K ﹤0.01% 7510
2026
Q1 		$465K Sell
31,200
-4,800
-13% -$107K ﹤0.01% 3349
2025
Q4 		$900K Buy
+36,000
New +$641K ﹤0.01% 2731
2025
Q1 		– Sell
-200
Closed -$1K – 9317
2024
Q4 		$1K Buy
200
+100
+100% +$999 ﹤0.01% 8277
2024
Q3 		$1K Sell
100
-1,700
-94% -$21.7K ﹤0.01% 8238
2024
Q2 		$19K Sell
1,800
-1,800
-50% -$19.5K ﹤0.01% 6940
2024
Q1 		$40K Sell
3,600
-10,500
-74% -$135K ﹤0.01% 6474
2023
Q4 		$197K Buy
14,100
+7,000
+99% +$94.1K ﹤0.01% 4697
2023
Q3 		$87K Buy
7,100
+2,900
+69% +$29.6K ﹤0.01% 5233
2023
Q2 		$37K Buy
4,200
+3,500
+500% +$21.1K ﹤0.01% 6136
2023
Q1 		$2K Hold
700
– – ﹤0.01% 8496
2022
Q4 		$1K Buy
700
+200
+40% +$583 ﹤0.01% 8878
2022
Q3 		$1K Buy
+500
New +$2.12K ﹤0.01% 9596

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Simplex Trading's OLMA Position: Q2 2026 in Review

Simplex Trading sold out of Olema Pharmaceuticals (OLMA) in Q2 2026, closing a stake of 11,127 shares — an estimated $149K sold.

Simplex Trading first reported a position in OLMA in Q4 2021 and held it in 12 quarters. The position peaked at $261K in Q4 2023. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Simplex Trading reported no remaining Olema Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 11,127 Olema Pharmaceuticals shares in Q2 2026, an estimated $149K.
  • Simplex Trading first reported a position in Olema Pharmaceuticals in Q4 2021 and held it in 12 quarters.
  • Simplex Trading's Olema Pharmaceuticals position peaked at $261K in Q4 2023.
  • 186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.